Development of life-expectancy tables for people with type 2 diabetes
Open Access
- 24 December 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 30 (7), 834-839
- https://doi.org/10.1093/eurheartj/ehn567
Abstract
To develop tables that report the life expectancy associated with levels of major modifiable risk factors for patients with type 2 diabetes. A set of tables reporting life-expectancy stratified by age–sex groups for combinations of modifiable risk was constructed based on predictions from the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model. This model is based on a system of parametric proportional hazards risk equations for estimating mortality and vascular complications of diabetes that have been estimated from 3642 patients from the UKPDS. The tables show substantial potential gains in life expectancy within every age group from modifying major risk factors. The estimated life expectancy of men at age of 55 years with type 2 diabetes, 5 years after diagnosis, varies between 13.2 years for a patient who smokes, has systolic blood pressure of 180 mmHg, a total:HDL cholesterol ratio of 8, and HbA1c of 10%, and 21.1 years for a non-smoker with SBP of 120 mmHg, total/HDL ratio of 4, and HbA1c of 6%. Life expectancy tables provide a potentially useful tool of conveying prognostic information to people with type 2 diabetes and suggest substantial scope for increasing longevity by improving modifiable risk factors.Keywords
This publication has 33 references indexed in Scilit:
- Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trialThe Lancet, 2007
- Numeric, Verbal, and Visual Formats of Conveying Health Risks: Suggested Best Practices and Future RecommendationsMedical Decision Making, 2007
- Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trialBMJ, 2007
- Computer Modeling of Diabetes and Its ComplicationsDiabetes Care, 2007
- Framingham, SCORE, and DECODE Risk Equations Do Not Provide Reliable Cardiovascular Risk Estimates in Type 2 DiabetesDiabetes Care, 2007
- Prediction of first coronary events with the Framingham score: A systematic reviewAmerican Heart Journal, 2007
- Can postponement of an adverse outcome be used to present risk reductions to a lay audience? A population surveyBMC Medical Informatics and Decision Making, 2007
- ADVANCE—Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baselineDiabetic Medicine, 2005
- Patient-based outcome results from a cluster randomized trial of shared decision making skill development and use of risk communication aids in general practiceFamily Practice, 2004
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998